|
Cardiovascular Pharmacology
Citations 301-310 of 1154 total displayed.
|
Past content
(since Jan 1999):
|
- Coronary Heart Disease
Angiographic and Clinical Outcomes in Patients Receiving Low-Molecular-Weight Heparin Versus Unfractionated Heparin in ST-Elevation Myocardial Infarction Treated With Fibrinolytics in the CLARITY-TIMI 28 Trial
- Marc S. Sabatine, David A. Morrow, Gilles Montalescot, Mikael Dellborg, Jose L. Leiva-Pons, Matyas Keltai, Sabina A. Murphy, Carolyn H. McCabe, C. Michael Gibson, Christopher P. Cannon, Elliott M. Antman, Eugene Braunwald for the Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)–Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators
Circulation 2005;112:3846-3854; published online before print as doi:10.1161/CIRCULATIONAHA.105.595397
[Abstract]
[Full text]
- Special Reports
Acute Heart Failure Syndromes: Current State and Framework for Future Research
- Mihai Gheorghiade, Faiez Zannad, George Sopko, Liviu Klein, Ileana L. Piña, Marvin A. Konstam, Barry M. Massie, Edmond Roland, Shari Targum, Sean P. Collins, Gerasimos Filippatos, Luigi Tavazzi for the International Working Group on Acute Heart Failure Syndromes
Circulation 2005;112:3958-3968, doi:10.1161/CIRCULATIONAHA.105.590091
[Full text]
- Heart Failure
Cost-Effectiveness of Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine Therapy for Blacks With Heart Failure
- Derek C. Angus, Walter T. Linde-Zwirble, S. William Tam, Jalal K. Ghali, Michael L. Sabolinski, Victor G. Villagra, Wolfgang C. Winkelmayer, Manuel Worcel for the African-American Heart Failure Trial (A-HeFT) Investigators
Circulation 2005;112:3745-3753, doi:10.1161/CIRCULATIONAHA.105.563882
[Abstract]
[Full text]
- Editorials
Urocortin: Advancing the Neurohumoral Hypothesis of Heart Failure
- John C. Burnett, Jr
Circulation 2005;112:3544-3546, doi:10.1161/CIRCULATIONAHA.105.584441
[Full text]
- Controversies in Cardiovascular Medicine
Importance of Race/Ethnicity in Clinical Trials: Lessons From the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
- Anne L. Taylor, Jackson T. Wright, Jr, Richard S. Cooper, Bruce M. Psaty, Anne L. Taylor, Jackson T. Wright, Jr, Richard S. Cooper, and Bruce M. Psaty
Circulation 2005;112:3654-3666, doi:10.1161/CIRCULATIONAHA.105.540443
[Full text]
- Heart Failure
Mortality and Morbidity Remain High Despite Captopril and/or Valsartan Therapy in Elderly Patients With Left Ventricular Systolic Dysfunction, Heart Failure, or Both After Acute Myocardial Infarction: Results From the Valsartan in Acute Myocardial Infarction Trial (VALIANT)
- Harvey D. White, Philip E.G. Aylward, Zhen Huang, Anthony J. Dalby, W. Douglas Weaver, Ståle Barvik, José Antonio Marin-Neto, Jan Murin, Rolf O. Nordlander, Wiek H. van Gilst, Faiez Zannad, John J.V. McMurray, Robert M. Califf, Marc A. Pfeffer for the VALIANT Investigators
Circulation 2005;112:3391-3399; published online before print as doi:10.1161/CIRCULATIONAHA.105.551143
[Abstract]
[Full text]
- Pediatric Cardiology
Intravenous Amiodarone for Incessant Tachyarrhythmias in Children: A Randomized, Double-Blind, Antiarrhythmic Drug Trial
- J. Philip Saul, William A. Scott, Stephen Brown, Pablo Marantz, Valeria Acevedo, Susan P. Etheridge, James C. Perry, John K. Triedman, Susan W. Burriss, Paul Cargo, Jay Graepel, Eeva-Kaarina Koskelo, Rebecca Wang for the Intravenous Amiodarone Pediatric Investigators
Circulation 2005;112:3470-3477, doi:10.1161/CIRCULATIONAHA.105.534149
[Abstract]
[Full text]
- Vascular Medicine
Prothrombotic Mutations, Hormone Therapy, and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration
- Céline Straczek, Emmanuel Oger, Marianne Beau Yon de Jonage-Canonico, Geneviève Plu-Bureau, Jacqueline Conard, Guy Meyer, Martine Alhenc-Gelas, Hervé Lévesque, Nathalie Trillot, Marie-Thérèse Barrellier, Denis Wahl, Joseph Emmerich, Pierre-Yves Scarabin for the Estrogen and Thromboembolism Risk (ESTHER) Study Group
Circulation 2005;112:3495-3500; published online before print as doi:10.1161/CIRCULATIONAHA.105.565556
[Abstract]
[Full text]
- Articles
Prothrombotic Mutations, Hormone Therapy, and Venous Thromboembolism Among Postmenopausal Women. Impact of the Route of Estrogen Administration
- Céline Straczek, Emmanuel Oger, Marianne Beau Yon de Jonage-Canonico, Geneviève Plu-Bureau, Jacqueline Conard, Guy Meyer, Martine Alhenc-Gelas, Hervé Lévesque, Nathalie Trillot, Marie-Thérèse Barrellier, Denis Wahl, Joseph Emmerich, Pierre-Yves Scarabin for the Estrogen and Thromboembolism Risk (ESTHER) Study Group
Circulation published November 21, 2005, doi:10.1161/CIRCULATIONAHA.105.565556
[Abstract]
- Articles
Mortality and Morbidity Remain High Despite Captopril and/or Valsartan Therapy in Elderly Patients With Left Ventricular Systolic Dysfunction, Heart Failure, or Both After Acute Myocardial Infarction. Results From the Valsartan in Acute Myocardial Infarction Trial (VALIANT)
- Harvey D. White, Philip E.G. Aylward, Zhen Huang, Anthony J. Dalby, W. Douglas Weaver, Ståle Barvik, José Antonio Marin-Neto, Jan Murin, Rolf O. Nordlander, Wiek H. van Gilst, Faiez Zannad, John J.V. McMurray, Robert M. Califf, Marc A. Pfeffer for the VALIANT Investigators
Circulation published November 21, 2005, doi:10.1161/CIRCULATIONAHA.105.551143
[Abstract]
|
|
